Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
about
Mathematical Modeling of Interacting Glucose-Sensing Mechanisms and Electrical Activity Underlying Glucagon-Like Peptide 1 SecretionFructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies
P2860
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
description
scientific article published on 09 December 2013
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2013
@uk
name
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
@en
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
@nl
type
label
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
@en
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
@nl
prefLabel
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
@en
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
@nl
P2860
P1476
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
@en
P2093
Nicolai Jacob Wewer Albrechtsen
Rune Ehrenreich Kuhre
P2860
P356
10.1586/17446651.2014.862152
P577
2013-12-09T00:00:00Z